Aurinia Pharmaceuticals is a late clinical-stage biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need.
2025/5/30 23:31:13
(AUPH:NASDAQ - AUP:TSX)